FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

Critical Safeguards: “In Case of Emergency” in Neuromuscular Disease

Activity Snapshot

Activity Type: 
Live, Virtual Webinar
Release Date: 
Friday, October 24, 2025

Faculty

Beth Kaufman, MD
Clinical Professor, Pediatrics

Stanford University School of Medicine

Jennifer Kwon, MD, MPH
Director, Pediatric Neuromuscular Program

University of Wisconsin – American Family Children’s Hospital

Daniel L. Menkes, MD, MHSA
Professor and Chair of Neurology

Oakland University William Beaumont School of Medicine

Carrie K Barker, MD
Pediatric Pulmonology

University of Wisconsin – Madison

Activity Overview: 

October 24, 2025
4 p.m.-5:30 p.m ET